India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

World Hepatitis Day is marked each year on July 28. Last year, WHO's Global Hepatitis Report 2024 made clear the enormous burden of viral hepatitis: more than 2 million people are newly infected with ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...